FOXP3 and acute coronary syndrome: A significant reduction of regulatory CD4+ cells or FoxP3+ cells, together with altered functional activities, was previously reported in patients with acute coronary syndrome or in vulnerable patients who had undergo at least two myocardial infarctions in medical history compared with both normal subjects and patients with stable angina [24–28].